Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-somatropin Extension in Children With Idiopathic Short Stature
NCT03255694Phase 2Active, not recruiting
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- May 2017
- Primary completion
- Jun 2030
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of peg-somatropin in Idiopathic Short Stature (ISS), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started May 2017; status: active, not recruiting.
02
Drugs
peg-somatropin
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on NCT03255694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03255694.